Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.

Gamze Ucan Gunduz,Ozgur Yalcinbayir,Sukru Cekic,Meral Yıldız,Sara Sebnem Kilic

Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab.

2021

Gamze Ucan Gunduz
Ozgur Yalcinbayir
Sukru Cekic
Meral Yıldız
Sara Sebnem Kilic

Purpose: Management of uveitis displays a particular challenge in childhood. This study aims to compare the efficacy and safety of infliximab (IFX) and adalimumab (ADA) in pediatric noninfectious u...

Keywords:

Refractory
Infliximab
Tumor necrosis factor alpha
Internal medicine
Etiology
Adalimumab
Arthritis
Disease
Medicine
Uveitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations